3-25737406-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP5
The NM_018297.4(NGLY1):c.931G>A(p.Glu311Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018297.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251102Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135696
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461754Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727182
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74406
ClinVar
Submissions by phenotype
Congenital disorder of deglycosylation Pathogenic:3
- -
- -
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 311 of the NGLY1 protein (p.Glu311Lys). This variant is present in population databases (rs201791209, gnomAD 0.01%). This missense change has been observed in individual(s) with NGLY1-related conditions (PMID: 27388694, 34712575). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 221576). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NGLY1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects NGLY1 function (PMID: 25900930). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Neurodevelopmental delay Pathogenic:1
- -
not provided Pathogenic:1
Published functional studies found this variant is associated with significantly reduced NGLY1 enzyme activity (PMID: 38628705); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25900930, 34712575, 27388694, 28807864, 32071843, 35565658, 32395402, 38628705, 36528660, 28750948) -
not specified Uncertain:1
Variant summary: NGLY1 c.931G>A (p.Glu311Lys) results in a conservative amino acid change located in the Transglutaminase-like domain (IPR002931) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 251102 control chromosomes (gnomAD). c.931G>A has been reported in the literature in individuals affected with Congenital Disorder Of Deglycosylation (examples: He_2015, Delanne_2021, Stanclift_2022). These data indicate that the variant may be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 34712575, 25900930, 27388694, 35243670, 36528660). ClinVar contains an entry for this variant (Variation ID: 221576). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at